benzothiophene has been researched along with raloxifene hydrochloride in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, PW; Barrett-Connor, E; Cox, DA; Harper, K; Mosca, L; O'Gorman, J; Sarkar, S | 1 |
| Li, J; Liu, B; Wang, M; Wu, X; Xie, Y; Xu, G; Yan, X; Yang, C | 1 |
| David, E; Fournier dit Chabert, J; Lemaire, M; Pellet-Rostaing, S; Perrin, J | 1 |
| Cooperwood, JS; Khan, MO; Musa, MA | 1 |
| Bolton, JL; Chandrasena, ER; Choi, J; Edirisinghe, PD; Hemachandra, LP; Kastrati, I; Thatcher, GR; Wang, YT | 1 |
| Chang, J; Im, S; Jeon, S; Jeong, K; Jo, Y; Kim, DH; Kim, J; Kim, KC; Kim, S; Kim, YE; Lee, H; Lee, JC; Lee, JY; Lee, W; Min, JY; Nam, TG; Noh, H; On, DI; Park, HJ; Park, JW; Park, SM; Seok, SH; Seong, JK; Song, D; Yeom, M; Yun, JW | 1 |
1 review(s) available for benzothiophene and raloxifene hydrochloride
| Article | Year |
|---|---|
Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
Topics: Breast Neoplasms; Drug Design; Estrogen Receptor alpha; Female; Humans; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Stilbenes; Structure-Activity Relationship; Tamoxifen; Thiophenes; Toremifene | 2007 |
1 trial(s) available for benzothiophene and raloxifene hydrochloride
| Article | Year |
|---|---|
Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia.
Topics: Adult; Aged; Aged, 80 and over; Causality; Female; Humans; Hypertriglyceridemia; Middle Aged; Osteoporosis; Pancreatitis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Triglycerides | 2001 |
4 other study(ies) available for benzothiophene and raloxifene hydrochloride
| Article | Year |
|---|---|
Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
Topics: Animals; Binding, Competitive; Bone Density; Drug Evaluation, Preclinical; Estrogen Receptor alpha; Female; Ligands; Mice; Molecular Structure; Piperazines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Thiophenes; Uterus | 2005 |
Efficient access to 2-aryl-3-substituted benzo[b]thiophenes.
Topics: Cyclization; Molecular Structure; Oxidation-Reduction; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Thiophenes | 2005 |
Raloxifene and desmethylarzoxifene block estrogen-induced malignant transformation of human breast epithelial cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Biomarkers; Breast; Catechols; Cell Line; Cell Transformation, Neoplastic; Cytochrome P-450 Enzyme System; Deoxyguanosine; DNA Adducts; Enzyme Induction; Epithelial Cells; Estrogens; Female; Histone Deacetylase Inhibitors; Horses; Humans; Oxidation-Reduction; Oxidative Stress; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes | 2011 |
Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay.
Topics: Antiviral Agents; COVID-19; Humans; Luminescence; Middle East Respiratory Syndrome Coronavirus; Raloxifene Hydrochloride; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2023 |